Under stress, metabolism is changing: specific up-or down-regulation of proteins and metabolites occurs as well as side effects. Distinguishing specific stress-signaling metabolites (alarmones) from side products (damage metabolites) is not trivial. One example is diadenosine tetraphosphate (Ap4A) -a side product of aminoacyl-tRNA synthetases found in all domains of life. The earliest observations suggested that Ap4A serves as an alarmone for heat stress in Escherichia coli. However, despite 50 years of research, the signaling mechanisms associated with Ap4A remain unknown. We defined a set of criteria for distinguishing alarmones from damage metabolites to systematically classify Ap4A. In a nutshell, no indications for a signaling cascade that is triggered by Ap4A were found; rather, we found that Ap4A is efficiently removed in a constitutive, nonregulated manner. Several fold perturbations in Ap4A concentrations have no effect, yet accumulation at very high levels is toxic due to disturbance of zinc homeostasis, and also because Ap4A's structural overlap with ATP can result in spurious binding and inactivation of ATP-binding proteins. Overall, Ap4A met all criteria for a damage metabolite. While we do not exclude any role in signaling, our results indicate that the damage metabolite option should be considered as the null hypothesis when examining Ap4A and other metabolites whose levels change upon stress.
Introduction
Metabolites are small, natural organic molecules. The vast majority of metabolites take part in catabolic and anabolic reactions, while others serve to initiate signaling cascades, as secondary messengers, including alarmones. In bacteria, alarmone production is induced during stress (e.g., starvation, heat, and oxidative stress) and their presence activates adequate cellular responses [1, 2] . In most cases, secondary messengers comprise specific metabolites with no additional roles. However, metabolites with dual roles are also known, including NAD -an essential enzymatic cofactor that also acts as a signaling molecule in regulating transcription, apoptosis, and DNA repair [3] . In recent years, another class of metabolites, damage metabolites, has attracted considerable attention [4, 5] . Damage metabolites are side products of enzymatic reactions, or products of nonenzymatic breakdown of other metabolites. Their accumulation can be deleterious, and thus, enzymatic pathways that convert them into harmless products have evolved. Under stress, damage metabolites may accumulate more rapidly, and their effects on cell growth and viability may become pronounced [6] . However, not every side product is a damage metabolite, and not every metabolite whose concentration rises under stress is an alarmone. Distinguishing between side effects and specifically induced effects of stress is not trivial. For example, increased mutation rates under stress have been proposed to be adaptive [7] , but high mutation rates can also be a mere side effect of stress [8] .
Diadenosine tetraphosphate (Ap4A) is the example of a metabolite that could belong to either categorydamage metabolite or alarmone. Discovered 50 years ago [9] , this molecule remains a mystery. Ap4A is generated as a side product of aminoacyl-tRNA synthetases (AARS) [10] , by ATP reacting with the amino acid-AMP intermediate, or directly, via reaction of two ATPs [11] . During normal growth, in vivo concentrations of Ap4A seem to vary widely from 0.05 to 1 lM in mammalian cells [12] to 1-3 lM in bacteria [13] . These relatively low concentrations (< 10 3 -fold lower than ATP) are the outcome of Ap4A hydrolases (ApaHs), and/or Ap4A phosphorylases (where phosphate acts as nucleophile instead of water), seen in all kingdoms of life. In Escherichia coli, Ap4A concentrations were reported to respond to external stimuli such as heat [14] , oxidative stress [15, 16] , and ethanol [17] . These observations led to the hypothesis that Ap4A functions as an alarmone [15, 18] . Throughout the years, Ap4A has been linked to a wide range of key biological functions ranging from heat-stress response in E. coli [14] to mammalian tear secretion [19] and is described in > 500 research reports. However, to date, no signaling pathways that are specifically triggered by Ap4A are known, certainly not in bacteria. On the other hand, knockout of ApaH results in high Ap4A levels, increased sensitivity to heat and starvation [20] , weakened stress-induced mutagenesis response [21] , decreased persister formation [22] , and inhibit sporulation [16] .
Two hypotheses should be therefore considered: (i) Ap4A is an alarmone with specific signaling and/or regulatory roles in stress, or (ii) Ap4A is a damage metabolite. These hypotheses are not necessarily mutually exclusive -Ap4A may have emerged as damage metabolite, and mechanisms for its removal have consequently evolved, but it may had also been recruited in some organisms for specific signaling. To assign Ap4A, or any metabolite, to one category or another, it is necessary to establish specific criteria.
An alarmone and/or a secondary messenger should meet the following criteria: 1 Alarmone levels must be regulated such that basal levels persist during ambient conditions and a transient concentration change is triggered by stress [23] . 2 An increase in concentration under stress is not indicative in itself. Rather, alarmone levels are controlled via production and/or degradation, whereby the corresponding enzymes are regulated, transcriptionally and/or at the protein level, in response to specific triggers [24, 25] . 3 Alarmone production and/or degradation via an artificially regulated enzyme would affect growth, under normal conditions and/or stress [26] [27] [28] . 4 Transcription factors or allosteric enzymes are found that are selectively modulated by the alarmone. These regulated proteins would be associated with other proteins whose levels change when alarmone levels change (e.g., via transcriptional regulation networks) [29] .
Not all criteria must be fulfilled. For example, changes in NAD levels are not induced as such, but they are sensed and can initiate a signaling cascade. Thus, while criterion 1 is irrelevant for NAD, criterion 4 has been met [30] .
On the other hand, distinct criteria of damage metabolites include: 5 It is a side product of a metabolic enzyme rather than being produced by a dedicated enzyme that is accordingly regulated [31] . 6 Enzyme(s) that degrade damage metabolites exist and degradation is constitutive rather than regulated [32] . 7 The damage metabolite can accumulate to some degree with no physiological effects yet become toxic upon exceeding a certain threshold, especially under stress. Accordingly, removal of a damage metabolite-degrading enzyme(s) is deleterious but not lethal [33] .
We attempted to systematically examine these criteria, using E. coli as a case study. We found that Ap4A is constitutively removed -its degradation is not regulated, neither transcriptionally nor at the enzyme level (criteria 1 and 2 not met). Artificially induced production, or complete degradation of the Ap4A, had no growth effect (criteria 3 not met) and proteins that sense and respond to change in Ap4A cellular level were not identified (criteria 4 not met). On the other hand, Ap4A is a side product of essential, metabolic enzymes, and its homeostasis is maintained by a constitutively expressed ApaH (criteria 5 and 6 fulfilled). Ap4A becomes toxic but not lethal, only when its concentration rises dramatically, and even then, only under stress conditions (criterion 7 fulfilled). Overall, Ap4A does not fit any of the alarmone criteria, while all damage metabolite criteria are fulfilled. The criteria and tools developed here, foremost, the laboratory subfunctionalization of E. coli's lysyl-tRNA synthetase (LysRS) to generate an Ap4A synthetase, can be applied to decipher the role of Ap4A, and of other stress-related metabolites, in other organisms.
Results

Ap4A hydrolase (ApaH)-deficient strains
The only currently available way of perturbing Ap4A levels has been via knockout of E. coli's ApaH, a symmetrical hydrolase which generates two ADP molecules and belongs to the serine/threonine phosphatase family [34, 35] . Several phenotypes associated with the apaH knockout have been reported, but their mechanistic basis remains unknown. Specifically, the apaH knockout was reported to have intracellular Ap4A levels that are~100-fold higher than wild-type and increased sensitivity to stress [20] [21] [22] .
We constructed a series of apaH genetic constructs, aiming to ensure that the observed DapaH phenotypes are a direct outcome of increased Ap4A concentration and not due to other, unknown secondary functions of ApaH (Table 1 ). The level of Ap4A in the DapaH strain, measured by LC-MS, during growth in minimal medium (M9 with 0.4% glucose; M9-Glc) increased 350-fold, from 0.2 lM in wild-type to 65 lM in DapaH (Table 1) . In rich media, the E. coli K12 DapaH strain exhibited the same maximal growth rate as the parental, wild-type strain, also upon serial transfer of exponentially growing cultures (Fig. 1A,B) . However, when cells grown in LB medium were transferred to minimal medium, the growth yield was lower in DapaH (Fig. 1C) . Accordingly, transfer of DapaH cells grown to stationary phase in minimal medium to fresh minimal medium led to a longer lag phase (Fig. 1D) . Additionally, as previously reported, growth in rich medium at 46°C was almost completely inhibited in DapaH and cells exhibited an elongated morphology (Fig. 1E,F) . However, cell death was not observed, at least within the first 3 h of incubation at 46°C ( Table 2) . As described later, we also compared the proteome of the apaH knockout to wild-type, aiming to uncover which proteins are up-or down-regulated at elevated Ap4A levels.
Regulation of ApaH
Following the apaH knockout characterization, we replaced the endogenous ApaH with various ApaH variants, chromosomally encoded and expressed under different promoters (Table 1 ). The Saccharomyces cerevisiae ATCC 204508/S288c Ap4A phosphorylase, Table 1 . Ap4A intracellular concentrations in the generated E. coli K12 strains. Cells were grown in M9-Glc medium for 24 h, diluted 100-fold in fresh M9-Glc, grown and pelleted at the exponential phase. Measurements of Ap4A concentrations were done in duplicate and mean values with standard deviation are presented. Apa2, was placed under the apaH promoter. Apa2 belongs to the HIT (histidine triad) superfamily. It is not a hydrolase, but rather an asymmetrical phosphorylase, generating ATP and ADP from Ap4A and phosphate, and shows no homology in structure, or sequence, to E. coli's ApaH. Both growth inhibition at 46°C ( Fig. 2A ) and the longer lag time in minimal medium (Fig. 2B ) of the apaH knockout were complemented by apa2. Accordingly, the cellular level of Ap4A was restored to a level that is ≥ 10-fold lower than wildtype and below the detection limit of our assay (Table 1) . Complementation by an enzyme that shares nothing but ApaH's ability to remove Ap4A suggests that the observed DapaH phenotype relates directly to elevated Ap4A levels, and not any secondary functions of ApaH. Furthermore, if Ap4A has some signaling role in heat stress and/or starvation, unregulated removal should have an effect. However, regulation (allosteric via a small molecule, or by an E. coli protein regulator) is unlikely to be recapitulated by the evolutionarily and biochemically unrelated Apa2. Furthermore, upon analyzing ApaH, we found that it exhibits low thermostability (T M % 50°C). This low melting point could relate to signaling of higher environmental temperatures. To examine this option, we engineered a thermostable variant of ApaH using computational design [36] . We generated an ApaH variant carrying 29 mutations and exhibiting a T M of 64°C, well above the observed heat-stress phenotype at 46°C (mutations are listed in Material and methods section). However, genomic complementation of the endogenous ApaH with this variant, ApaH_D7, showed wild-type-like behavior including at 46°C ( Fig. 2A,B) . Thus, as indicated by the Apa2 complementation, ApaH regulation at the enzyme level is unlikely.
We also tested complementation by ApaH mutants with impaired activity to detect the concentration threshold of Ap4A above which phenotypes are observed ( Fig. 2A,B) . Active-site mutations may also cause misfolding and loss of protein, as we observed with the ApaH mutants. Thus, we used the stabilized ApaH_D7 variant to introduce two active-site mutations, H120A and H227A. Both of these mutants produced soluble, folded proteins, yet H120A was essentially inactive, while the Ap4A hydrolyzing activity of H227A decreased by 240-fold compared to wild-type ApaH. Complementation with the enzymatically inactive ApaH-H120A resulted in a phenotype indistinguishable from the knockout strain, DapaH. The ApaH-H227A mutant resulted in growth inhibition that is slightly weaker than the apaH knockout ( Fig. 2A,B) , although its Ap4A level was similar to that of DapaH ( Table 1) . As the cellular Ap4A concentrations were compared on the basis of the culture's optical density and dry cell weight, it may well be that the actual Ap4A levels differ due to different cellular morphology.
Replacement of not only of the hydrolase itself (Apa2 instead of ApaH) but also of its transcriptional regulation had no effect either. Specifically, we generated constructs expressing Apa2 in the pZA vector -a low copy number plasmid with expression under the anhydrotetracycline (AHT) promoter. This construct was expressed in both the DapaH and the parental strain, alongside a control construct bearing an inactive Apa2 mutant (Apa2-H161A). Expression of Apa2 or its inactive variant in the parental strain had no effect on growth in LB medium at 46°C (Fig. 3A) . The growth rate of the Apa2 complemented DapaH strain in either LB medium at 46°C or in minimal medium at 37°C was identical to the parental K12 strain as long as the inducer, AHT, was present, while DapaH cells expressing the inactive Apa2 mutant behaved as the DapaH strain (Fig. 3B,C) .
The above results indicated that E. coli growth rate is not affected by replacement of its endogenous ApaH by another enzyme that removes Ap4A (Apa2). However, small differences cannot be detected by parallel growth and monitoring absorbance. We thus performed a direct growth competition between a K12 strain expressing yeast Apa2 (in addition to the endogenous ApaH) and an identical control strain expressing an inactive Apa2 mutant. Expression of active Apa2 resulted in nonregulated removal of Ap4A, and to levels below detection (in oppose tõ 0.2 lM in the parental K12 strain). To quantify the ratio of the competing versus the control cells, the competing strain contained a chloramphenicol resistance marker. The effect of chloramphenicol marker was determined by competing K12 strains with and without it (both expressing inactive Apa2). The direct competition experiment also indicated no significant growth advantage or disadvantage of Ap4A nonregulated removal neither in LB (Fig. 3D ) nor in M9-Glc medium (Fig. 3E) .
Overall, it appears that ApaH's function is not regulated, neither at the enzyme level nor transcriptionally, and certainly not under the conditions tested here; thus, criteria 1 and 2 are not fulfilled. Furthermore, Ap4A levels in the strain expressing yeast Apa2 were significantly reduced -≤ 0.02 lM compared to 0.2 lM in the wild-type (Table 1 ), yet within the perturbation range expected for a signaling molecule. If Ap4A has a signaling role, altered regulation and degradation kinetics should both have some effect (criterion 3 not fulfilled). The above results are, however, entirely consistent with Ap4A being a damage metabolite that is constitutively removed (criterion 6 met). Its accumulation at low levels has no effect, while very high levels (≥ 100-fold compared to wild-type) inhibit growth, but only under challenging conditions and without causing cell death (criterion 7 met). Cells were mixed at equal ratios and this inoculate was grown over 48 h at 37°C in LB medium (D) and M9-Glc medium (E). The ratio of the competing strain (active yeast Apa2; undetectable Ap4A levels) over the control strain (inactive Apa2; WT-like Ap4A levels) is indicated in dark red squares. These ratios are essentially identical to those seen in a parallel competition of a K12 strain carrying a chloramphenicol resistance marker with an identical strain with no such marker (black circles). All growth experiments were done in three repeats and the mean values with standard deviation are presented.
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LysU does not affect the presumed Ap4A-triggered phenotypes
If degradation of Ap4A is not regulated, perhaps synthesis is. Lysyl-tRNA synthetases (LysRS) is considered the main producer of Ap4A in E. coli, with two isoforms, LysS and LysU [37] . LysS is constitutively expressed and is likely to be responsible for housekeeping aminoacylation. LysU's expression is thought to be triggered by heat stress, and it has thus been suggested to act primarily as an Ap4A synthetase [38, 39] . A lysU deletion strain (DlysU) was reported to grow normally at low temperature (28°C) but poorly at 44°C, and this growth defect was ascribed to disruption of Ap4A-mediated heat-stress signaling [37] . Furthermore, E. coli cells evolved to grow at high temperature exhibited elevated lysU levels, and its deletion rendered them thermosensitive [40] . However, a later publication reported that lysU deletion has no effect on growth at high temperature [41] . Given these conflicting reports, we tested the DlysU phenotype. In E. coli K12, we could not identify any significant growth difference, or any other observable phenotype, upon deletion of lysU, including at elevated growth temperatures. Furthermore, the DlysU and the DlysS strains showed the very same growth rates at ambient and high temperatures in both rich and minimal media.
Laboratory subfunctionalization of LysRS to generate an Ap4A synthetase
An enzyme whose primary function is Ap4A synthesis is not known, neither in E. coli nor in other organisms. However, in nature, secondary, moonlighting functions often evolve to become the primary function of a duplicated, paralogue gene (subfunctionalization) [42] . We engineered a subfuntionalized LysU variant that produced Ap4A yet had no aminoacylation function. We established an assay for Ap4A synthetase activity in crude cell lysates based on luminescent detection of ATP generated upon Ap4A hydrolysis. By combining screens of gene libraries and site-directed mutagenesis, we generated a LysU variant capable of executing only Ap4A synthesis. The libraries included mutations in and around LysU's active-site aimed at increasing the Ap4A synthetase activity, and consensus mutations to compensate for the stability losses associated with the function altering mutations (Table S1 ). Following three rounds of mutagenesis and screening for higher synthetase activity, variant A2 (K178E, L231M, V268T, E362R, E373R, and F426Y) was isolated. To abolish the aminoacylation activity, we first tried to truncate the N-terminal tRNA-binding domain, but this resulted in an almost complete loss of activity. We thus mutated three residues known to mediate tRNA binding (R77A, Q95A, and T130A) [43, 44] . The new LysU variant, dubbed LysU_Ap4Asynth, exhibited 2-fold increased Ap4A synthetase activity with no detectable aminoacylation activity (Fig. 4A) .
LysU_Ap4Asynth was expressed from a pZA plasmid in various E. coli strains, thus enabling us to examine the outcome of artificially triggered production of Ap4A. Wild-type LysU and an inactive variant devoid of both aminoacylation and Ap4A synthesis were used as controls. E. coli K12 cells expressing these three different LysU variants exhibited the very same growth rate as wild-type, including under heat shock and starvation ( Fig. 4B ), although the cellular concentrations of Ap4A were up to 4.5-fold higher in the strains overexpressing wild-type LysU and its subfunctionalized variant, LysU_Ap4Asynth ( Table 1) .
As expected in the DapaH strain, overexpression of LysU, and especially of LysU_Ap4Asynth, resulted in a longer lag phase in minimal medium (Fig. 4C) . However, the Ap4A concentrations in the DapaH cells expressing these LysU variants, or with no LysU overexpression, were all similar. This could be due to the fact that Ap4A concentrations were measured during the exponential phase and not during the lag phase, and also because of biases in the calculated concentrations due to differences in cell morphology.
The above result is meaningful, because removal of ApaH results in a huge increase in Ap4A levels (> 300-fold; Table 1 ) and thus causes a global physiological disturbance. It seems, however, that a mild perturbation at the range expected for a signaling molecule has no effect. Furthermore, in direct competition assay, the ratio between cells expressing LysU_A-p4Asynth and cells expressing an inactive LysU variant did not change during growth in LB (Fig. 4D ) or M9-Glc medium (Fig. 4E ) at 37°C for 48 h. Thus, a mild increase in Ap4A levels does not confer any advantage or disadvantage.
Overall, these data suggest that untimely and elevated Ap4A production has no observable physiological effect, unless the accumulating Ap4A is not removed (criterion 7 met). Mild increases, e.g., fourfold, had no observable effect, and particularly not higher resistance to heat stress. If anything, elevated Ap4A levels seem to induce heat sensitivity rather than heat resistance. This result is inconsistent with Ap4A playing a role in specific signaling (criterion 3 not met), but is entirely consistent with Ap4A being a damage metabolite.
Proteomics of E. coli DapaH
We examined the changes in E. coli's proteome in the apaH knockout whereby Ap4A levels are~350-fold elevated. We opted for growth in minimal medium and during the exponential phase, rather than heat shock, to examine changes that occur prior to and not during stress. Additionally, although DapaH cells did not die at 46°C, Fig. 4 . Artificially induced Ap4A production has no observable phenotype. (A) Ap4A synthetase and aminoacylation activities of LysU-evolved variants, LysU_A2 and LysU_Ap4Asynth, compared to wild-type LysU. Measurements were done in duplicate and ratio of the mean values with standard deviations is presented. (B) Induced expression of LysU in E. coli K12 has no growth effect, regardless if wild-type LysU is expressed, or LysU-inactive (InT), or the engineered Ap4A synthase, LysU_Ap4Asynth. Shown is growth in M9-Glc at 37°C; identical growth of these strains was also seen at 46°C. (C) Growth effects in M9-Gl at 37°C were observed in the DapaH strain and upon induction of LysU expression with AHT. Wild-type LysU, but not its inactivated mutant, InT, caused a lag phase that was further elongated by the engineered Ap4A synthetase variant LysU_Ap4Asynth. (D,E) Growth competitions between an E. coli K12 strain expressing the Ap4A-producing LysU variant and a control strain expressing a LysU-inactive variant over 48 h at 37°C in LB medium (D) and M9-Glc medium (E). The ratio of the competing strain (~4.5-fold higher Ap4A levels) over the control strain (WT-like Ap4A levels) is indicated in purple squares, and the control competition is indicated in black circles. Growth experiments were done in three repeats and the mean values with standard deviation are presented.
they did not grow and hence limited cell mass. Protein intensities in the DapaH strain were compared to the parental, wild-type strain. We only considered changes in proteins where ≥ 2 peptides were consistently identified. Overall,~2000 proteins, namely about half of the E. coli proteome, were reliably detected in both conditions.
The proteome changes were relatively subtle. Only nine proteins were identified whose levels decreased by 2-to 13-fold in DapaH in at least two independent experiments (Table 3) . No up-regulated proteins were observed, not reproducibly and given our analysis criteria.
The proteins listed in Table 3 can be divided into three groups: (i) proteins regulated by Zur -the Zn 2+ DNA-binding transcriptional repressor (YkgM, ZinT, and ZnuA); (ii) enzymes belonging to aromatic amino acid biosynthesis pathways (AroF, TyrA, TrpE, and TrpA); (iii) proteins that regulate the starvation sensing during stationary phase (RspA and RspB). The last two groups are related because a shortage of aromatic amino acids is known to be a hallmark of starvation [45] . It therefore appears that elevated Ap4A levels result in a lower ability to sense starvation, thus accounting for the slower recovery of DapaH strain after starvation and probably also for the growth arrest at 46°C. Indeed, we observed no indications for a heat-stress responsemost heat shock proteins and chaperones were reliably detected and showed no changes.
Ap4A and Zn 2+ homeostasis
A distinct change in response to elevated Ap4A levels was the decrease in expression of three out of the five operons controlled by the zinc transcriptional factor, Zur. Down-regulation of the other two operons was also observed (pliG and znuB,C), with a milder,~1.5-fold decrease. The result is in accordance with the affinity of Zur for those operons. The strongest binding was reported to the ykgM,O operon and the weakest to pliG [46] . The down-regulation of Zur-regulated genes, including the Zn 2+ importer, suggests that the DapaH strain has elevated cellular zinc levels, or perhaps that erroneously senses high levels. If the DapaH strain has increased intracellular zinc concentration, then the apaH knockout strain might exhibit some advantage in a Zn 2+ -depleted media. Indeed, while the parental K12 strain showed no growth in minimal medium containing the metal chelator EDTA, the DapaH strain grew after a lag phase to a final cell density that is similar to that without a chelator (Fig. 5) . Although EDTA chelates a range of bivalent metals including Mg 2+ and Ca
2+
, its affinity toward zinc is ≥ 10 5 -fold higher, and the concentrations of the latter were higher than that of EDTA.
Overall, the proteomics data are consistent with the observed phenotype of the DapaH strain in relation to its compromised response to starvation. Furthermore, these data do not indicate a linkage between Ap4A and heat stress. However, we observed a previously unreported linkage between Ap4A and Zn 2+ homeostasis that may relate to the observation that Ap4A binds Zn 2+ with high affinity [47] . Although the affinity measurement was later questioned [48], Zn 2+ is also known to activate the Ap4A synthetase activity of AARS [49] . However, while Ap4A may contribute to zinc storage under some conditions, a specific role for Ap4A in sensing Zn 2+ depletion is unlikely, given that, as discussed in the next section, none of the . We attempted to identify Ap4A-binding proteins by pull-down with biotin-labeled Ap4A. We tested several biotinylated analogs, yet the only one that gave consistent results had the biotin tethered to the N8 of the adenine ring (as opposed to attachment via the ribose or adenine-N6).
Owing to the minimal interference of N8 modification, this analog was also the only one that could be enzymatically synthesized from N8-biotinylated ATP using Apa2, the yeast Ap4A phosphorylase, which catalyzes the conversion of adenosine-5 0 -phosphosulfate (APS) and ATP into Ap4A [52] . Pull-downs were performed in two alternative modes: The lysate was preincubated with biotin-Ap4A, and the streptavidin beads were added later; or with streptavidin beads precoated with biotin-Ap4A. In both modes, ATP was present in the binding step to favor selective Ap4A binders. After extensive washing, the remaining, bound proteins were identified by shotgun proteomics. As controls, pulldowns were performed with either biotin or biotin-ATP.
Potential Ap4A binders were identified on the basis of a cumulative score that included three criteria: (i) The number of unique peptide fragments that are observed (two as a minimum); (ii) > 2-fold enrichment in the biotin-Ap4A samples relative to the biotin and biotin-ATP controls; and (iii) consistent enrichment in more than one pull-down. The highest scoring proteins are listed in Table 4 . A few of these were previously implicated with Ap4A binding (IMPDH, DnaK). Interestingly, most of these putative Ap4A binders are regulatory proteins, with particular enrichment of ssDNA-binding proteins. However, although all pulldowns were done in the presence of ATP to minimize unspecific binding, nearly all the identified proteins are known ATP binders.
The two proteins showing the highest enrichments in all pull-down experiments were inosine monophosphate dehydrogenase (IMPDH; previously implicated with Ap4A [51]) and a transcriptional regulatory protein, NrdR. These were further characterized to determine if Ap4A binding is biologically relevant. . Accordingly, the CBS domain binds phosphorylated nucleosides such as ATP or AMP that may comprise allosteric regulators of IMPDH, and also binds ssDNA [56] . Bacterial IMPDHs are divided into two classes: Class I comprises enzymes that are allosterically activated by ATP and are permanently octameric; Class II enzymes exhibit ordinary kinetics, are tetramers in the apo state, and shift to octamers in the presence of NAD or ATP [57] . E. coli's IMPDH (ecIMPDH) belongs to Class II, yet aiming to examine how evolutionary conserved Ap4A binding is, we also tested a IMPDH from P. aeruginosa that belongs to Class I.
In agreement with its dominance in pull-downs, purified ecIMPDH exhibited tight binding to biotinylated-Ap4A (Fig. 6A) . Soluble ATP or Ap4A did not inhibit binding, suggesting a large avidity effect (multiple immobilized Ap4A molecules and IMPDH's octameric state). Using radioactively labeled Ap4A and equilibrium dialysis, we confirmed that ecIMPDH binds soluble Ap4A with fivefold higher affinity than ATP. This affinity ratio indicates that Ap4A binding is physiologically irrelevant. Cellular ATP concentrations in E. coli are in the range of 1-10 mM [58, 59] , while Ap4A's concentration is in the range of 0.2 lM (Table 1 ). In fact, ATP dominates (≥ 14-fold molar Growth of the parental E. coli K12 and the DapaH strain at 37°C in M9-Glc, and in same medium supplemented with 0.2 mM EDTA. Growth experiments were done in three repeats and the mean OD 600 nm values with standard deviation are presented.
excess) even at the abnormally high Ap4A concentrations observed in the apaH knockout (~70 lM). Indeed, we could not identify any physiologically relevant modulation of ecIMPDH by Ap4A. Neither ATP nor Ap4A influenced the enzymatic activity of ecIMPDH (Fig. 6B) . Both ligands inhibited the binding of ecIMPDH to ssDNA, but in the same manner, and in any case, significant inhibition by Ap4A was only observed at 0.1 mM, i.e., at a physiologically irrelevant range (Fig. 6C) .
In contrast to the Class II ecIMPDH, the Class I IMPDH of P. aeruginosa (paIMPDH) is allosterically activated by ATP [60] . We found that Ap4A is a weaker allosterically activator of paIMPDH and competes for the same binding site as ATP (Fig. 6D) . However, the effect of Ap4A could only be observed at ATP concentrations below 1 mM (Fig. 6E,F) . Furthermore, even at 0.1 mM ATP (10-fold below the minimal reported cellular concentration), the effect of Ap4A was only seen at 10 lM (50-fold above the normal cellular levels).
Overall, our results indicate that although in vitro Ap4A binds and modulates IMPDHs belonging to both Class I and II, in vivo Ap4A is unlikely to be relevant because its effects are completely masked by ATP. From the point of view of IMPDH's physiological role, our results suggest that ATP comprises an inhibitor of ssDNA binding. Thus, ATP is not only an allosteric and oligomeric regulator of IMPDHs [60] but may also affect their function as transcriptional regulators. Specifically, IMPDHs have been suggested to suppress transcription of genes involved in adenylate nucleotide synthesis [56] and our results suggest that ATP binding to the CBS domain of IMPDH may alleviate this suppression.
NrdR also binds Ap4A as an ATP surrogate
The second-best Ap4A binder identified by our pulldowns was NrdR -a zinc-finger transcriptional regulator that modulates the expression of several operons encoding ribonucleotide reductases (RNRs) according to the abundance of deoxyribonucleoside triphosphates relative to ribonucleotides [61, 62] . NrdR has been reported to bind ATP [62] . We confirmed NrdR's strong affinity to biotinylated Ap4A immobilized onto streptavidin plates, as opposed to no binding of immobilized ATP (Fig. 7A) . Subsequently, we compared the effect of Ap4A and ATP on NrdR's binding to DNA. NrdR regulates RNRs expression through binding to so-called 'NrdR boxes', 16 bp motifs within RNRs promoters. We used a 237 bp dsDNA stretch that corresponds to nrdA promoter region and assayed NrdR's binding as for IMPDH. Although Ap4A showed a slightly stronger inhibitory effect, under our assay conditions, ATP completely inhibited DNA binding at 0.1 mM concentrations (Fig. 7B ).
Other putative Ap4A-binding proteins
The effect of Ap4A on DNA binding was also tested for transcriptional regulators HU and HNS, which were also identified in the pull-downs, but our in vitro assays indicated that Ap4A did not modulate DNA binding of these proteins.
DnaK and ClpB are reported Ap4A binders [20, 50] and DnaK was also identified in our pull-downs. Both proteins (DnaK and ClpB) are part of a chaperone complex that includes DnaJ and GrpE [63] . We tested the effect of Ap4A on the refolding activity of the DnaK-DnaJ-GrpE-ClpB complex but did not observe a significant effect. As the DnaK-DnaJ-GrpE complex is also involved in bacteriophage k DNA replication, we tested the effect of ATP and Ap4A on ssDNA binding. ATP strongly activated DnaK's binding to ssDNA, while Ap4A had no effect.
In conclusion, the pull-down experiments did not identify selective Ap4A binders, let alone proteins where Ap4A binding has potential relevance in vivo. As is clear from the detailed analysis of IMPDH and NrdR, Ap4A binds these proteins as an ATP surrogate. Furthermore, although IMPDH and NrdR bind Ap4A at the lM range, and in some in vitro assays exhibit higher affinity to Ap4A compared to ATP, a biological relevance is unlikely. Firstly, because the cellular ATP concentrations are normally ≥ 5000-fold higher compared to Ap4A (1-10 mM versus 0.2 lM, respectively). Secondly, none of the genes/proteins that are under regulation of the proteins identified as potential Ap4A binders exhibited changes in expression in the apaH knockout. For example, the levels of proteins under NrdR's regulation (NrdA, NrdB, NrdE, and NrdI) did not change at elevated Ap4A levels (Table 3) . Thus, the effects of Ap4A on NrdR do not seem to differ from those of ATP, certainly not in the concentration range that is physiologically relevant. Conversely, none of the proteins whose expression significantly changes in apaH knockout is linked, even indirectly, to the identified Ap4A binders (criterion 4 not met).
Discussion
It is generally easier to prove the existence of a given biological mechanism, or entity, than to prove its absence (which in some cases, would be impossible). Nonetheless, a set of Occam's razor criteria can be applied to distinguish between two alternative hypotheses: a damage metabolite versus a specific signaling role. In the case of Ap4A in E. coli, all criteria for damage metabolite were met as opposed to none of those indicating specific signaling. However, it is clear that these results do not completely rule an involvement of Ap4A in signaling. Firstly, our assays were limited to starvation and heat stress, and Ap4A could be involved in signaling other challenges. Secondly, Ap4A could be indirectly involved, for example, via the modulation of other alarmones such as ppGpp.
Finally, a lack of signaling function in E. coli does not exclude the possibility that Ap4A acts as secondary messenger, and especially in mammalian cells [64] . The new tools we have established allow controlled perturbations of cellular Ap4A concentrations. Beyond the routinely applied knockout of ApaH, an Ap4A synthetase is now available that may assist in the identification of signaling roles of Ap4A, in E. coli or another organism. Given the complexity of the cellular milieu, we recognize the risk of claiming that we have exhausted the search for function. On the other hand, not every compound in the cell must have function. There exists a Panglossian tendency to assume that 'any trait has to have a good use to explain its presence'. However, 'the default assumption should now be that the products of metabolite damage are merely adventitious, particularly if there is an efficient system to remove them' [31] . As shown here, Ap4A is not only efficiently removed in E. coli but also constitutively -neither the expression nor the enzymatic activity of its ApaH are regulated. Additionally, only massive accumulation of Ap4A such as in the case of ApaH knockout induces phenotypic changes. Unlike in the case of alarmone, where even twofold increase above basal level has effect, slight Ap4A increase or decrease observed with expression of LysU variants and Apa2, respectively, did not affect cell fitness. Effects of mild Ap4A increase or decrease were not observed even in growth competitions that can detect relatively subtle effects. These results are in clear contrast to what had been observed with other alarmones, most distinctly with ppGpp that bears obvious analogy to Ap4A. Subtle changes in ppGpp levels, on the order of 10-fold, affected growth rate [23] . Overexpression of ppGpp synthase results in severe growth inhibition [27] , while strains lacking ppGpp show complex phenotypes, from amino acid auxotrophy to morphological changes [26] .
Our results also indicate two potential toxic effects of Ap4A accumulation. Firstly, Ap4A mimics ATP. The pull-down experiments identified known ATP binders. Their characterization indicated that Ap4A can displace ATP and inhibit those proteins. Indeed, enzyme inhibition by mimicry is a common effect of damage metabolites. For example, spontaneously modified products of NADH and NADPH at neutral pH cannot serve as electron acceptors or donors, but they bind and inhibit dehydrogenases [65] . Secondly, high Ap4A concentrations seem to disrupt Zn 2+ homeostasis. The proteome analysis revealed that high Ap4A levels inhibit expression of Zn 2+ importers. Accordingly, the growth advantage of the DapaH strain in Zn 2+ -deficient medium suggests that high Ap4A levels lead to increase in Zn 2+ levels. In E. coli, and as far as we know, in other organisms, Ap4A is not produced by a dedicated enzyme, but rather, it is a side product of one of the most ancient and essential enzyme classes, AARSs. Although Ap4A is probably present in all organisms, not all AARS produce it, certainly not to the same degree. This observation, and the deleterious effects of accumulating Ap4A, may suggest that, unless beneficial, Ap4A production by AARSs would have been eliminated by evolution. However, whether Ap4A production can be eliminated with no effect on AARS function is unknown. Thus, AARSs could be yet another example, out of many, where the most accessible evolutionary solution was an enzyme that degrades the damage metabolite rather than eliminating its production in the first place. 
Material and methods
Bacterial strains and procedures
The applied E. coli strains are listed in Table 1 . E. coli K12 DapaH strain was generated by P1 transduction [66] using the apaH knockout from Keio collection [67] as a starting point. The strains where the apaH gene was replaced with other genes were generated using the k-red system [68] , whereby the kanamycin cassette in E. coli K12 DapaH strain was replaced with the open reading frame of the complementing gene followed by a chloramphenicol cassette.
The open reading frame (ORF) of the apa2 gene (Gene ID: 852143) was PCR amplified from the genome of S. cerevisiae ATCC 204508/S288c, and cloned into a pZA vector with anhydrous tetracycline inducible promoter [69] . The list of primers used for cloning is provided as Table S2 . The inactive variant Apa2-H161A was generated by site-directed mutagenesis [70] . Plasmids were transformed to E. coli K12 or its DapaH strain, using ampicillin (100 lgÁmL
À1
) as a selection marker. Growth experiments were done in LB or in M9 medium plus 0.4% glucose (M9-Glc) without presence of antibiotics. A preculture in LB or M9, with antibiotics (2 mL; grown for 24 h), was diluted to OD 600 nm = 0.2, and 3-lL inoculates were transfer to 150 lL of LB or M9-Glc, in 96-well microtiter plates. Growth was subsequently followed in a plate reader (BIO-TEK, Synergy HT) at 37°C with shaking (for 30 s with 5-min intervals) while monitoring OD 600 nm . Growth at elevated temperature was followed in LB. LB culture was inoculated as described above and growth at 46°C was monitored in a plate reader. The inoculated culture was overlaid with 100 lL of mineral oil to prevent evaporation. Growth of strain carrying pZA plasmids (encoding ApaH, Apa2, or LysU variants) was done as above, except that ampicillin and anhydrous tetracycline (AHT; 200 ngÁmL À1 ) as inducer were added.
Growth competitions
We used two platform strains, both containing E. coli's original ApaH gene: unmodified E. coli K12, or E. coli K12 DapaH::apaH-CAP that contains the original apaH gene alongside a chloramphenicol (CAP) cassette used as a marker. E. coli K12 that carried pZA_Apa2 H161A plasmid (inactive Apa2) served as the reference strain. The competing strains were based on E. coli K12 DapaH::apaH-CAP. They carried either pZA_Apa2 H161A plasmid (inactive apa2) or pZA_Apa2 (active apa2). These strains were grown separately in LB plus Amp (100 lgÁmL
À1
) until OD 600 nm~1 . They were then mixed at a 1 : 1 ratio. An aliquot of this mix was immediately diluted and plated in parallel on LB agar plus Amp, and LB agar plus Amp plus CAP to measure the initial cell counts of each strain. Another aliquot of the starting mix was diluted 1000-fold in 8 mL of LB plus Amp plus AHT (100 ngÁmL À1 ), and in 8 mL of M9-Glc plus Amp plus AHT (100 ngÁmL À1 ). After 24 h growth at 37°C (200 rpm, 50 mL falcon tubes), the resulting cultures were plated in parallel on selective LB agar to measure the cell counts of the two competing strains. An aliquot of 24-h culture was diluted 1000-fold in the fresh medium (serial passage) and after 24 h of growth at 37°C, the cultures were plated again on selective agar to measure the cell counts.
The control competition was of [E. coli K12 pZA_Apa2 H161A] versus [E. coli K12 DapaH::apaH-CAP pZA_Apa2 H161A] thus determining the effect of chloramphenicol cassette at wild-type-like Ap4A levels (inactive Apa2, in both strains). Subsequently, [E. coli K12 pZA_Apa2 H161A] was competed with [E. coli K12 DapaH::apaH-CAP pZA_Apa2] to measure the fitness effects associated with decreased Ap4A level.
The same procedure was used for the fitness assay with the increased levels of Ap4A. E. coli K12 carrying pZA_InT plasmid (inactive variant of LysU) was competing against E. coli K12 DapaH::apaH-CAP pZA_InT and E. coli K12 DapaH::apaH-CAP pZA_Ap4Asynth.
Data are presented as percentage of selected strain (number of colonies on LB agar + Amp + CAP) versus total cell number (number of colonies on LB agar + Amp) with standard deviation from three biological replicas.
ApaH cloning, purification, activity, and thermal denaturation assay
The ORF of apaH gene (Gene ID: 944770) was PCR amplified from the genome of E. coli K12 and cloned into a pET21a vector with a C-terminal 6-His tag. A synthetic gene encoding the designed ApaH_D7 (D7 design contains following mutations: I17Q, H21D, E24N, T26D, G28K, D47K,  Y51F, F74A, S78R, K114R, T124A, Q130E, D138E, S147N,  F150W, D153E, H162R, R168T, G171D, N189D, Q191R,  Y195K , S196C, P206E, G215S, A218S, E219K, S222N, and E238P) was cloned in pET21a vector with the same tag. The H120A and H227A mutants of ApaH_D7 were generated by site-directed mutagenesis. The recombinant plasmids were transformed into E. coli BL21 (DE3) and cultured in 100 mL LB medium. Protein expression was induced with 1 mM IPTG at OD 600 nm % 0.6. After being cultured for another 6 h at 37°C, cells were harvested, collected by centrifugation, and resuspended in 5 mL of lysis buffer (50 mM HEPES, pH 7.8, and 150 mM KCl, 15 mM imidazole). After sonication and removal of pellet, the proteins in the supernatant were loaded on a Ni-NTA column that was preequilibrated with the binding buffer (50 mM HEPES, pH 7.8, and 150 mM KCl). The ApaH variants were eluted with 200 mM imidazole, elution fractions were pulled, the buffer was exchanged to 50 mM HEPES, pH 7. , and 4.1 mgÁmL À1 wild-type ApaH, ApaH_D7, ApaH_D7 H120A, and ApaH_D7 H227A, respectively. Protein purity was assessed by electrophoresis and the samples were stored at À20°C. The thermal stability of ApaH variants was measured following heat-induced unfolding. Solutions of 15 lM enzyme containing 5 9 SYPRO Orange dye (Invitrogen, Waltham, MA, USA) were heated from 4 to 99°C in a 7500 Fast RealTime PCR system (Applied Biosystems, Foster City, CA, USA) and unfolding was followed by measuring the change in fluorescence excitation, 488 nm; emission, 570 nm. Measurements were conducted in duplicates and the midpoint of denaturation (T M ) was determined as the maximum of the first derivative for each temperature.
Ap4A hydrolase activity was assayed using 0.15 lM (wildtype, and stabilized variant) or 12 lM (D7 variants H120A and H227A) enzyme, 1 mM Ap4A, in 50 mM HEPES, pH 7.8, and 150 mM KCl, 7 mM MgCl 2 . Aliquots of the reaction mixtures (1.5 lL) were taken after 5, 10, and 60 min, and analyzed by thin-layer chromatography (TLC) using silicagel-60 plates with fluorescent indicator (catalog no. 5554; Merck, Kenilworth, NJ, USA). The mobile phase comprised a mixture of isopropanol : 2,4-dioxane : water : 25% ammonia solution at a ratio of 2 : 4 : 4 : 3 [71] . The plates were dried and visualized by UV light. Samples were run in duplicates and the UV images were analyzed by IMAGEJ software (NIH, Bethesda, MD, USA).
Cloning, expression, and purification of Apa2
Full-length apa2 gene (Gene ID: 852143) was PCR amplified from the genome of S. cerevisiae ATCC 204508/S288c and cloned into a pET-21a vector, with a C-terminal hexahistidine tag. The recombinant plasmid was transformed into E. coli BL21 (DE3) cultured in 100 mL LB medium. The expression of the proteins was induced with 1 mM IPTG when OD 600 nm reached 0.6. After being cultured for another 16 h at 20°C, cells were harvested and collected by centrifugation at 4000 g for 15 min, and resuspended in 5 mL of lysis buffer (20 mM TRIS, pH 7.8, and 150 mM KCl, 15 mM imidazole). The purification procedure is the same as described above for ApaH. Purified protein (5.7 mgÁmL À1 ) in 20 mM TRIS, pH 7.8, and 150 mM KCl buffer was stored at À20°C for further use.
LysU engineering and characterization
The ORF of lysU gene (Gene ID: 948645) was PCR amplified from the genome of E. coli and cloned into pET-21a, with a C-terminal 6-His tag. The lysU gene library was generated using the ISOR method [72] , including functional mutations in aminoacylation domain and consensus mutations derived from a sequence alignment (the list of library mutation primers is in Table S2 ). The assembly PCR was optimized to yield~2.5 mutations per gene, thus resulting in~50% of active clones. The library was cloned in pET-21a and transformed into E. coli BL21 (DE3) cells. Single colonies were inoculated in 500 lL LB media and grown overnight at 37°C in deepwell plates. This preculture (8 lL) was used to inoculate 800 lL of 2YT medium. After 2.5 h of growth at 37°C with shaking, expression was induced with 1 mM IPTG, and growth was continued for 6 h at 37°C. The cell pellet was lysed in 20 mM TRIS pH 7.5, 150 mM KCl, 7 mM MgCl 2 with bensonase (1 UÁlL À1 ), lysozyme (0.3 mgÁmL À1 ), and protease inhibitor (S8830; Sigma Aldrich, St. Louis, MO, USA). For assaying Ap4A synthesis, 5 lL of clarified lysate was added to 45 lL of reaction buffer (20 mM TRIS pH 7.5, 150 mM KCl, 7 mM MgCl 2 ) plus mixture with 1 mM ATP. The reaction was incubated for 1 h at 37°C and stopped by heating (5 min at 65°C). The unreacted ATP was hydrolyzed by calf intestine phosphatase (4 U) for 3 h min at 37°C, and the phosphatase was inactivated by heating at 85°C for 5 min. A 10 lL aliquot of the inactivated reaction mix was added to 9.75 lL aliquot of the luciferase ATP determination kit (LBR-T010, Proteinkinase.de, Kassel, Germany) plus recombinant human ApaH in order to hydrolyze the synthesized Ap4A to AMP and ATP (0.25 lL of 1 mgÁmL À1 ; the enzyme was cloned in pET-21a with C-terminal His tag and purified as Apa2). The assay was calibrated such that the amount of ATP generated by Ap4A hydrolysis was proportional to the luminescence signal. Variants from the first round of evolution that showed higher activity than wild-type LysU were shuffled in the second round of evolution. The variants with the highest Ap4A synthetase activity were characterized as described below. The mutations in the tRNA-binding domain (R77A, Q95A, and T130A) were introduced by site-directed mutagenesis protocol [70] . The engineered LysU variants were expressed in E. coli BL21 (DE3) cells cultured in 100 mL LB. Expression was induced with IPTG, and growth was continued for 6 h as above. The purification procedure was the same as for Apa2 described above. 
Ap4A synthesis and aminoacylation assay
Determination of cellular Ap4A concentrations
Extract preparation E. coli K12 wild-type and DapaH cultures were grown in M9-Glc for 24 h, and used to inoculate a fresh 10 mL culture of M9-Glc (at 100 dilution). The cultures were grown with shaking at 37°C and cells were pelleted by 3-min centrifugation at 10 000 g, at OD 600 nm % 0. The reaction progress was followed by TLC (method described above); at 10% of conversion, the enzyme was eliminated by addition of acetonitrile (1 : 1 v/v) to prevent further reaction progress. Precipitated enzyme was removed by centrifugation, solution was diluted twofold in water and filtered through 0.2-lm filters. To prepare internal standard mix stock, the reaction mixture was diluted in water providing 5 lM concentration of 13 
LC-MS analysis
The LC-MS/MS instrument which consisted of Acquity Iclass UPLC system (Waters, Milford, MA, USA) and Xevo TQ-S triple quadrupole mass spectrometer (Waters) equipped with an electrospray ion source and operated in positive ion mode was used for analysis of nucleoside phosphates. MASSL-YNX and TARGETLYNX software (v.4.1; Waters) were applied for the acquisition and analysis of data. The analysis was done on a 50 9 2 mm i.d., 3-lm 100 A Luna-NH2 column equipped with 4.0 9 2.0 security guard amine cartridge (both Phenomenex) with mobile phases A (10 mM ammonium formate, pH 5.0 adjusted with 10% acetic acid, followed by addition of 40 mL of acetonitrile) and B (1 mM ammonium formate, pH 10.6 adjusted with 29% ammonia, followed by addition of 17 mL of acetonitrile) at a flow rate of 0.3 mLÁmin À1 and column temperature 25°C. A 10-min gradient was as follows: linear increase from 30 to 70% B during 4 min, then increase to 90% in 0.5 min, followed by return to 30% B in the next 0.5 min, and equilibration for 5 min. Samples kept at 4°C were automatically injected in a volume of 5 lL. For mass spectrometry, argon was used as the collision gas with flow 0.10 mLÁmin À1 . The capillary voltage was set to 2.50 kV, source temperature -150°C, desolvation temperature -600°C, and desolvation gas flow -800 LÁh À1 .
Analytes were detected using multiple reaction monitoring applying following parameters: Ap4A [retention time 3.57 min; transition 837. Cellular concentration was determined in two ways: based on the dry weight of the extracted cells and OD 600 nm . The total intracellular volume: the dry weight of the extracted cells (measured using cultures that are treated identically to those used for metabolite extraction) multiplied by the ratio of aqueous volume to cellular dry weight. The ratio of aqueous volume to cellular dry weight is 0.0023 LÁg À1 for E. coli [73] . The total intracellular volume was calculated on the basis of the OD 600 nm : total number of cells (OD 600 nm = 1 corresponds to 10 9 cellsÁmL
À1
) multiplied by the single cell volume (1 lm 3 [74] ). The measured concentration was multiplied with dilution factor (sample volume/total cellular volume) to determine intracellular concentration of Ap4A. Concentrations calculated by both methods were similar.
Synthesis of biotin-labeled Ap4A
Synthesis of 8-[(6-amino)-hexyl]-amino-Ap4A-biotin 
Proteomics and pull-down experiments
Proteomics
The culture was prepared in the same way as described above for metabolomic analysis. The cell pellets were frozen in liquid nitrogen and analyzed by MS.
Pull-down experiments
E. coli K12 MG1655 cells were cultured in 10 mL of LB medium and pelleted at OD 600 % 0.5. Cell pellets were isolated by centrifugation, washed, and resuspended in 50 mM HEPES, pH 7.8, 150 mM NaCl, and 1 mM MgCl 2. Cells were disrupted by sonication. The total protein concentration was measured by the bicinchoninic acid (BCA) assay kit (23227, Thermo Scientific, Waltham, MA, USA) and all lysates were all diluted to 2 mg proteinÁmL
À1
. Pull-downs were performed with either precoated magnetic beads (Merck Millipore, LSKMAGT10) or by preincubation with biotinylated ligands. Overall, three parallel pull-down experiments were performed. Experiment #1 included the following steps: (i) The rinsed beads (1 mg) were incubated with 100 lL of 20 lM biotin, bioATP, or bioAp4A for 1 h at 4°C; (ii) Unbound ligands were removed by rinsing with HEPES buffer (7 9 250 lL); (iii) 50 lL of E. coli lysate and 50 lM ATP were incubated with biotinylated beads for 1.5 h at 4°C; and (iv) Unbound proteins were removed by rinsing with HEPES buffer (7 9 250 lL) and beads were analyzed by MS. Experiment #2 included the following steps: (i) 25 lM biotin, bioATP or bioAp4A, were incubated with E. coli lysate plus 50 lM ATP (100 lL total volume) for 1 h at 4°C; (ii) Rinsed beads (1 mg) were added to the above mixture and incubated for an hour at 4°C; and (iii) Unbound proteins were rinsed by washing with HEPES buffer (7 9 250 lL) and beads were analyzed by MS. Experiment #3 included the following steps: (i) Beads (4 mg) were incubated with 400 lL of 25 lM bioAp4A for 1 h at 4°C; (ii) Unbound ligand was removed by rinsing with HEPES buffer (7 9 250 ll); (iii) BioAp4A beads were incubated with 200 lL of E. coli lysate plus 50 lM ATP for 1.5 h at 4°C; (iv) Unbound proteins were removed by rinsing with HEPES buffer (7 9 250 lL), and in the last rinse, the beads were split to four aliquots (4 9 100 lL) and buffer was removed; and (v) Proteins bound to BioAp4A beads were eluted with 100lL of HEPES buffer, 10, 50, or 100 lM Ap4A solution, and analyzed by MS.
For the MS analysis, samples were subjected to in-solution, on-bead, tryptic digestion. Proteins were first reduced by incubation with dithiothreitol for 30 min at 60°C, and alkylated with 10 mM iodoacetamide in the dark for 30 min at 21°C. Proteins were then subjected to digestion with trypsin (Promega, Madison, WI, USA) for 16 h at 37°C. The digestions were stopped by trifluroacetic acid (1%). Following digestion, peptides were desalted using solid-phase extraction columns (Oasis HLB; Waters). The samples were stored in À80°C until further analysis. For lysate analysis, samples were subjected to in-solution tryptic digestion using a modified Filter Aided Sample Preparation protocol (FASP). Sodium dodecyl sulfate buffer (SDT) included: 4% (w/v) SDS, 100 mM Tris, pH 7.6, and 0.1 M DTT. Urea buffer (UB): 8 M urea (Sigma, U5128) in 0.1 M Tris, pH 8.0, and 50 mM ammonium bicarbonate. Cells were dissolved in 100 lL SDT buffer and lysed for 3 min at 95°C. Then spin down at 16 000 RCF for 10 min. One hundred microgram of sample was mixed with 200 lL UB and loaded onto 30 kDa molecular weight cutoff filters and spin down. Two hundred microliter of UB was added to the filter unit and centrifuged at 14 000 g for 40 min. Samples were alkylated using 100 lL IAA, followed by two washing with ammonium bicarbonate. Trypsin was then added and samples were incubated at 37°C overnight. Additional amount of trypsin was added and incubated for 4 h at 37°C. Digested proteins were then spun down to a clean collecting tube, 50 lL NaCl 0.5 M was added and spin down, acidified with trifloroacetic acid, desalted using HBL Oasis, speedvac to dry, and stored in À80°C until analysis.
Liquid chromatography
ULC/MS grade solvents were used for all chromatographic steps. Each sample was loaded using split-less nano-ultra performance liquid chromatography (10 kpsi nanoAcquity; Waters). The mobile phase was: (A) H 2 O + 0.1% formic acid and (B) acetonitrile + 0.1% formic acid. Desalting of the samples was performed online using a reversed-phase C18 trapping column (180 lm internal diameter, 20 mm length, 5 lm particle size; Waters). The peptides were then separated using a T3 HSS nano-column (75 lm internal diameter, 250 mm length, 1.8 lm particle size; Waters) at 0.35 lLÁmin
À1
. Peptides (proteomics analysis) were eluted from the column into the mass spectrometer using the following gradient: 4-20% B in 155 min, 20-90% B in 5 min, maintained at 95% for 5 min and then back to initial conditions. Peptides (pull-down analysis) were eluted from the column into the mass spectrometer using the following gradient: 4-35% B in 105 min, 35-90% B in 5 min, maintained at 95% for 5 min and then back to initial conditions.
Mass spectrometry
The nanoUPLC was coupled online through a nanoESI emitter (10 lm tip; New Objective, Woburn, MA, USA) to a quadrupole orbitrap mass spectrometer (Q Exactive HF or Q Exactive Plus; Thermo Scientific) using a FlexIon nanospray apparatus (Proxeon, Thermo Scientific).
Data were acquired in DDA mode, using a Top20 method. For Q Exactive HF analysis, MS1 resolution was set to 60 000 (at 400 m/z) and maximum injection time was set to 20 ms. MS2 resolution was set to 15 000 and maximum injection time of 60 ms. For Q Exactive Plus analysis, MS1 resolution was set to 70 000 (at 400 m/z) and maximum injection time was set to 120 ms. MS2 resolution was set to 35 000 and maximum injection time of 60 ms.
Data processing and analysis
Raw data were imported into the Expressionist Ò software (Genedata, Basel, Switzerland) and processed as described previously [75] . The software was used for retention time alignment and peak detection of precursor peptides. A master peak list was generated from all MS/MS events and sent for database searching using Mascot v2.5 (Matrix Sciences, Boston, MA, USA). For proteomics lysate analysis, MS/ MS spectra were also searched using MSGF+ (Integrative Omics, https://omics.pnl.gov/software/ms-gf). Data were searched against the E. coli K12 protein sequences as downloaded from UniprotKB (http://www.uniprot.org/), and appended with 125 common laboratory contaminant proteins. Fixed modification was set to carbamidomethylation of cysteines and variable modifications were set to oxidation of methionines and deamidation of N or Q. Search results were then filtered using the PeptideProphet [76] algorithm to achieve maximum false discovery rate of 1% at the protein level. Peptide identifications were imported back to Expressions to annotate identified peaks. Quantification of proteins from the peptide data was performed using an in-house script [75] . For lysate analysis, protein intensity was normalized based on the total ion current. For pull-down experiments, the data were not normalized. Protein abundance was obtained by summing the three most intense, unique peptides per protein. A Student's t-test, after logarithmic transformation, was used to identify significant differences across the biological replica. Fold changes were calculated based on the ratio of arithmetic means of the case versus control samples.
Purification and characterization of IMPDHs and NrdR
Full-length guaB (Gene ID: 946985) and nrdR (Gene ID: 947437) genes were PCR amplified from the genome of E. coli and guaB gene (Gene ID: 880535) from P. aeruginosa. The genes were cloned into a pET-21a vector, with a C-terminal hexahistidine tag. The expression and purification procedure for IMPDHs were the same as for ApaH, while NrdR expression was for 16 h at 16°C after IPTG induction and purification process the same as described above for Apa2.
IMPDHs (11 mgÁmL À1 ) were stored in 50 mM HEPES pH 7.8, 150 mM KCl, and 7 mM MgCl 2 buffer, and NrdR (8.9 mgÁmL À1 ) in 50 mM TRIS pH 8.3, 300 mM NaCl, 5 mM DTT, 100 lM ZnCl 2 , and 20% glycerol buffer. Proteins were stored at À20°C. For assaying IMPDH's activity, 2 lM enzyme was incubated with 1 mM NAD and 2 mM IMP in reaction buffer of 50 mM HEPES pH 7.8, 150 mM KCl, and 7 mM MgCl 2 . The reaction was monitored by increase in absorbance at 340 nm (Synergy HT, BIO-TEK) in 96-well plates (655801; Greiner Bio-one, Kremsmu¨nster, Austria).
ELISA assays
Binding to DNA was performed by an ELISA-like assay. The promoter region of gsk (Gene ID: 946584) and nrdA (Gene ID: 946612) genes were amplified from E. coli genome using specific primers, followed by a second PCR using a forward biotinylated primer (Table S1 ). The PCR products were purified, and the DNA concentration was determined by measuring A 260 nm (NanoDrop 2000; Thermo Scientific). Streptavidin-coated plates (StreptaWell; Roche, Basel, Switzerland) were incubated for 30 min with 100 lL solutions of either biotin, biotinylated ATP or biotinylated Ap4A (at 2 lM), or biotinylated dsDNA (3 ngÁlL À1 ). The wells were washed (50 mM HEPES pH 7.8, 150 mM KCl, 7 mM MgCl 2 ), and the ones coated with dsDNA were treated with 0.125 M NaOH (3 9 100 lL) to generate ssDNA [77] . After further washing, the wells were blocked with 1% BSA. Coated wells were incubated for 
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